Transcutaneous Auricular Neurostimulation (tAN) for Premenstrual Dysphoric Disorder (PMDD) and Perimenopause
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorTexas Christian University
About this trial
Transcutaneous Auricular Neurostimulation (tAN) will be administered to women with premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), and perimenopause. The investigators will examine whether tAN improves symptomology by collecting self-report data before the intervention, during the intervention, and following the intervention.
Eligibility criteria
Qualifiers
Assigned female at birth
Age 18 to 45
Naturally cycling
Regularly occurring menstrual cycle
Disqualifiers
Using hormonal birth control
Pregnant or lactating/breastfeeding
History of seizures
Implanted devices
Trial design
Treatments tested in this trial
- transcutaneous auricular neurostimulation (tAN)
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Texas Christian University
Lead sponsor
Spark Biomedical, Inc.
Collaborator
Source ClinicalTrials.gov